4th Quarter - Report

CAPITOL HILL CONSULTING GROUP for ENDO PHARMACEUTICALS

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation; H.R. 6160, Stop Tampering of Prescription Pills Act of 2012.

LobbyistCovered position, as disclosed
BILL K BREWSTER —
DAVID JORY —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2632 (112th), H.R. 6160 (112th), S. 1410 (112th)

Medicare/Medicaid MMM

General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement

LobbyistCovered position, as disclosed
BILL K BREWSTER —
DAVID JORY —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.